Article Text

See original article:

other Versions

  • You are currently viewing an earlier version of this article (July 31, 2007).

PDF

THE EFFECTS OF CANNABIS ON PULMONARY STRUCTURE, FUNCTION AND SYMPTOMS
  1. Sarah Aldington (sarah.aldington{at}mrinz.ac.nz)
  1. Medical Research Institute of New Zealand, New Zealand
    1. Mathew Williams (mathew.williams{at}mrinz.ac.nz)
    1. Medical Research Institute of New Zealand, New Zealand
      1. Mike Nowitz (mike.nowitz{at}otago.ac.nz)
      1. Pacific Radiology, Wellington, New Zealand
        1. Mark Weatherall (mark.weatherall{at}otago.ac.nz)
        1. Wellington School of Medicine & Health Sciences, New Zealand
          1. Alison Pritchard (alison.pritchard{at}mrinz.ac.nz)
          1. Medical Research Institute of New Zealand, New Zealand
            1. Amanda McNaughton
            1. Medical Research Institute of New Zealand, New Zealand
              1. Geoffrey Robinson
              1. Medical Research Institute of New Zealand, New Zealand
                1. Richard Beasley (richard.beasley{at}mrinz.ac.nz)
                1. Medical Research Institute of New Zealand, New Zealand

                  Abstract

                  Background: Cannabis is the most widely used illegal drug worldwide. Long term use of cannabis is known to cause chronic bronchitis and airflow obstruction, however the frequency of macroscopic emphysema, the dose-response relationship and the dose equivalence of cannabis with tobacco has not been determined.

                  Methods: A convenience sample of adults from the Greater Wellington Region was recruited into four smoking groups; cannabis only, tobacco only, combined cannabis and tobacco and non-smokers of either substance. Their respiratory status was assessed using high resolution CT scanning, pulmonary function tests and a respiratory and smoking questionnaire. Associations between respiratory status and cannabis use were examined by analysis of covariance and logistic regression.

                  Results: A total of 339 subjects were recruited into the four groups. A dose-response relationship was found between cannabis smoking and reduced FEV1/FVC and sGaw, and increased TLC. For measures of airflow obstruction, one cannabis joint had a similar effect to between 2.5 and 6 tobacco cigarettes. Cannabis smoking was associated with decreased lung density on HRCT scans. Macroscopic emphysema was detected in 1/75 (1.3%), 15/92 (16.3%), 17/91 (18.9%) and 0/81 subjects in the cannabis only, combined cannabis and tobacco, tobacco alone and non-smoking groups respectively.

                  Conclusions: Smoking cannabis was associated with a dose-related impairment of large airways function resulting in airflow obstruction and hyperinflation. In contrast, cannabis smoking was seldom associated with macroscopic emphysema. The 1:2.5 to 6 dose equivalence between cannabis joints and tobacco cigarettes for adverse effects on lung function is of major public health significance.

                  • CT scan
                  • Cannabis
                  • Lung function
                  • Smoking
                  • Tobacco

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                  Linked Articles

                  • Corrections
                    BMJ Publishing Group Ltd and British Thoracic Society
                  • Editorial
                    Peter Lange